• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Genelux Corporation

    10/22/24 4:12:19 PM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GNLX alert in real time by email
    SC 13G/A 1 tm2426664d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    GENELUX CORPORATION

    (Name of Issuer)

     

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

     

    36870H103

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ¨ Rule 13d-1(b)
         
      ¨ Rule 13d-1(c)
         
      x Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 36870H103 Schedule 13G Page 2 of 5

     

    1

    NAME OF REPORTING PERSON

     

    Aladar Szalay

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ¨ (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING PERSON WITH:

    5

    SOLE VOTING POWER

     

    3,408,581 (1)

    6

    SHARED VOTING POWER

     

    5,000 (2)

    7

    SOLE DISPOSITIVE POWER

     

    3,408,581 (1)

    8

    SHARED DISPOSITIVE POWER

     

    5,000 (2)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    3,413,581 (3)

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ¨

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.9% (4)

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1) Consists of (i) 599,821 shares of common stock held by The Szalay 2010 Retained Annuity Trust, (ii) 2,258,760 shares of common stock held by The Szalay 2009 Irrevocable Trust and (iii) 550,000 shares of common stock held by The Szalay 2010 Children’s Trust, for which the reporting person has sole voting and dispositive power.
    (2) Consists of 5,000 shares of common stock held by the reporting person’s spouse, for which the reporting person has shared voting and dispositive power.
    (3) Consists of (i) 599,821 shares of common stock  held by The Szalay 2010 Retained Annuity Trust, (ii) 2,258,760 shares of common stock held by The Szalay 2009 Irrevocable Trust and (iii) 550,000 shares of common stock held by The Szalay 2010 Children’s Trust, for which the reporting person has sole voting and dispositive power, and (iv) 5,000 shares of common stock held by the reporting person’s spouse, for which the reporting person has shared voting and dispositive power.
    (4) This percentage is calculated based on 34,535,471 shares of common stock outstanding as of August 12, 2024, as reported in Genelux Corporation’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, filed with the Securities and Exchange Commission on August 14, 2024.

     

     

     

     

    CUSIP No. 36870H103 Schedule 13G Page 3 of 5

     

    Item 1(a).

    Name of Issuer:

    Genelux Corporation

       
    Item 1(b).

    Address of Issuer’s Principal Executive Offices:

    2625 Townsgate Road, Suite 230

    Westlake Village, California 91361

       
    Item 2(a).

    Names of Person Filing:

     

    Aladar Szalay

       
    Item 2(b).

    Address of Principal Business Office, or, if none, Residence:

     

      7704 North Fork Rd., Highland, CA 92346
       
    Item 2(c).

    Citizenship:

     

    United States

     

    Item 2(d).

    Title of Class of Securities:

     

    Common Stock, par value $0.001 per share

       
    Item 2(e).

    CUSIP No.:

     

    36870H103

     

    Item 3. Not Applicable.

     

    Item 4. Ownership.

     

      (a) Amount beneficially owned:
         
        See Row 9 of cover page.

     

      (b) Percent of class:
         
        See Row 11 of cover page.

     

      (c) Number of shares as to which the person has:

     

      (i) Sole power to vote or to direct the vote:
         
        See Row 5 of cover page for the Reporting Person.

     

      (ii) Shared power to vote or to direct the vote:
         
        See Row 6 of cover page for the Reporting Person.

     

      (iii) Sole power to dispose or to direct the disposition of:
         
        See Row 7 of cover page for the Reporting Person.

     

      (iv) Shared power to dispose or to direct the disposition of:
         
        See Row 8 of cover page for the Reporting Person.

     

     

     

     

    CUSIP No. 36870H103 Schedule 13G Page 4 of 5

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    Not Applicable.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not Applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not Applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not Applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10. Certifications.

     

    Not Applicable.

     

     

     

     

    CUSIP No. 36870H103 Schedule 13G Page 5 of 5

     

    SIGNATURE

     

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated: October 22, 2024  
       
           /s/ Aladar Szalay
      Aladar Szalay

     

     

    Get the next $GNLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GNLX

    DatePrice TargetRatingAnalyst
    10/29/2024$8.00Buy
    Guggenheim
    8/28/2024$10.00Buy
    ROTH MKM
    11/27/2023$35.00Buy
    H.C. Wainwright
    9/12/2023$40.00Buy
    Maxim Group
    2/15/2023$10.00Speculative Buy
    The Benchmark Company
    More analyst ratings